NYSTATIN-TRIAMCINOLONE ACETONIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Nystatin-triamcinolone Acetonide, and what generic alternatives are available?
Nystatin-triamcinolone Acetonide is a drug marketed by Pharmaderm and is included in one NDA.
The generic ingredient in NYSTATIN-TRIAMCINOLONE ACETONIDE is nystatin; triamcinolone acetonide. There are eight drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the nystatin; triamcinolone acetonide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Nystatin-triamcinolone Acetonide
A generic version of NYSTATIN-TRIAMCINOLONE ACETONIDE was approved as nystatin; triamcinolone acetonide by FOUGERA PHARMS INC on October 8th, 1985.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for NYSTATIN-TRIAMCINOLONE ACETONIDE?
- What are the global sales for NYSTATIN-TRIAMCINOLONE ACETONIDE?
- What is Average Wholesale Price for NYSTATIN-TRIAMCINOLONE ACETONIDE?
Summary for NYSTATIN-TRIAMCINOLONE ACETONIDE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 2 |
DailyMed Link: | NYSTATIN-TRIAMCINOLONE ACETONIDE at DailyMed |
US Patents and Regulatory Information for NYSTATIN-TRIAMCINOLONE ACETONIDE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pharmaderm | NYSTATIN-TRIAMCINOLONE ACETONIDE | nystatin; triamcinolone acetonide | OINTMENT;TOPICAL | 062603-001 | Oct 9, 1985 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |